Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee votes ITL on bill to mandate insurance coverage for continuous glucose monitors
Summary
After extended debate about clinical benefit, cost and federal/state funding implications, the committee voted to recommend “inexpedient to legislate” (ITL) on a bill that would have expanded insurer coverage of continuous glucose monitoring (CGM) devices beyond current medically necessary uses.
A House committee voted to recommend ITL (inexpedient to legislate) on a bill that would have required insurers to cover continuous glucose monitors (CGMs) more broadly, concluding that questions about clinical benefit for non‑insulin patients and potential costs to premiums and the state remained unresolved.
Why it mattered: supporters framed CGMs as a tool that can improve real‑time glucose management and potentially reduce complications; opponents and department analysts said the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
